Canine parvovirus vaccine
AssigneeCornell Research Foundation, Inc.
InventorsMax J. G. Appel, Leland E. Carmichael
Life of this patent
Estimating the term…
Abstract
The present invention relates to the method of protecting dogs against canine parvoviruses. More specifically, the present invention relates to a method of producing an inactivated (killed) canine parvoviral vaccine from a native virulent strain of CPV for use as a vaccine in dogs against disease caused by virulent canine parvoviruses.
Claims6
The method of protecting dogs against virulent canine parvovirus which comprises inoculating an animal with inactivated canine parvovirus vaccine prepared in accordance with a process which comprises the steps of growing a strain of canine parvovirus in a non-oncogenic cell culture and then inactivating the virus.
Dependencies are inferred from the claim text.